Cipher Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsCipher Pharmaceuticals

Cipher Pharmaceuticals(CPHR)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Conzip	Tramadol	2010-05-07	2030-2040	Pain , Fever , Ankylosing spondylitis , Rheumatoid arthritis , Osteoarthritis , Adenomatous polyposis coli , Dysmenorrhea
Lipofen	Fenofibrate	2006-01-11	2024-2033	Hypercholesterolemia , Coronary artery disease , Dyslipidemias , Hypertriglyceridemia , Hyperlipoproteinemias , Periodontal diseases , Infectious skin diseases , Gram-negative bacterial infections , Oral candidiasis , Gram-positive bacterial infections
Natroba	Spinosad	2011-01-18	2023-2033	Lice infestations

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

,

postoperative pain

,

,

,

ulcerative colitis

,

,

healthy volunteers/patients

,

,

,

acquired immunodeficiency syndrome

,

,

chronic hepatitis c

,

systemic lupus erythematosus

,

alzheimer disease

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use